A Prospective Study on Hypolipidaemic Effects in Fresh and Dried Ginger Varieties

  • Shah Murad HOD Pharmacology, IMDC Pakistan.
  • Shahina . AP Biochemistry at KIMS Karachi Pakistan.
  • Abdul Qudoos Arain AP Pharmacology at HBSMC, Islamabad Pakistan.
  • A Azmi Assoc Prof of Pharma at IMC Sialkot Pakistan.
Keywords: Hypolipidemic effects, Ginger, VLDL


Background: The secretion of VLDL is influenced by the availability of apolipoprotein (apo) B in the liver and the activities of regulatory enzymes involved in the assembly and transport of VLDL, including microsomal transfer protein and acyl-coenzyme A (CoA):cholesterol acyltransferase . Dyslipidemia is well known factor to increase incidence of heart diseases. This may lead to development of atherosclerotic plaques which is major etiological factor for establishing coronary artery disease (CAD). Hypolipidemic drugs used in allopathy include Statins, Fibric acids, Niacin, and Resins but all have their low compliance due to frequent side effects. Medicinal herbs like Onion and Ginger are hypolipidemic agents commonly used as flavoring agents and making foods spicy and tasty. We have compared hypolipidemic potential between these two medicinal herbs.

Methods: The study was conducted at Ghurki Trust teaching hospital, Lahore from January to June 2017. Eighty secondary hyperlipidemic patients were enrolled after getting written consent which was approved by Ethics committee of the hospital. They were divided in two equal groups comprising 40 patients in each group. Group-I was treated by Ginger 10 grams daily in three divided doses for 2 months. Group-II was advised to take Onion 200 grams daily in divided amount with each meal i.e.; breakfast, lunch, and dinner for two months.

Results: After two months therapy it was observed by statistical analysis that 10 grams ginger reduced TC (total cholesterol) of 38 hyperlipidemic patients 12.4 gm/dl and LDL-C (low density lipoprotein cholesterol) 27.3 mg/dl. In group-II, onion reduced TC in 35 patients 17.9 mg/dl and LDL-C 14.8 mg/dl. Changes in tested parameters are significant biostatistically with p-values <0.01 to <0.001.

Conclusion: We concluded from this research work that Onion and Ginger reduces risk of CAD by decreasing plasma total cholesterol and LDL cholesterol.


1. Rebora TG, Nomave GG, Sandhu MS, Day NE, Luben R, Bingham SA, Peters RJ, Wareham NJ, Khaw KT. Physical activity, C-reactive protein levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Eur J Cardiovasc Prev Rehabil. 2015;13(6):970-6.
2. Yulva G, Fulkarrh T, Furnoveya M, Kawaguchi K, Mizuno T, Aida K, Uchino K. Blood lipids and CAD. Biosci Biotechnol Biochem 2011;61:102-4.
3. Polay TR, Bahirr VT, Malook MB, Vareya TL, Saliha B, Sipahib T, Oybak Dönmez, E. Metabolic syndrome and antioxidant agents. Journal of Ethnopharmacology 2011; 124 (3): 416-420.
4. Sookerva E, Anderson M, Bruckert, Eric; Labreuche, Julien; Amarenco, Pierre. Herbs have hypolipidemic effects but their wide range of pharmacological effects should be considered. Atherosclerosis 2010;21(2):353-61.
5. Bekarh B, Saqalom B, Panchal S.K., Poudyal H., Iyer A., Nazer R., Alam M.A., Diwan V., Kauter K., Sernia C., Campbell F., Ward L. High- carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling. J. Cardiovasc. Pharmacol. 2011;57:611-24.
6. Muatqadd G, Folika G, Jia G., Aroor A.R., Whaley-Connell A.T., Sowers J.R. Fructose and uric acid: Is there a role in endothelial function? Curr. Hypertens Rep. 2014;16:434.
7. Feela M, Kaluve N, Goto T, Teraminami A, Lee JY, Ohyama K, Funakoshi K, Kim YI. Drugs for metabolic syndrome and their complications. J Nutr Biochem 2012;23:768-76.
8. Fuqrawa S, Mittal MK, Florin T, Perrone J, Delgado JH, Osterhoudt KC. Allopathy related hypolipidemic drugs. Ann Emerg Med 2010;50(5):587-590.
9. Parasandve T, Faure P, Rossini E, Wiernsperger N, Jaiyawi U, Pawove T.
Medicinal plants and its wastage. Diabetes. 2013; 48: 353-57.
10. Gaqavanyve Y, Assayed ME. Radioprotective effects of black seed (Nigella sativa) oil against hemopoietic damage and immunosuppression in gamma- irradiated rats.Immunopharmacol Immunotoxicol. 2010;32:284–296.
11. Kunitomo M. Oxidative stress and atherosclerosis treated by onion. J Phytoch. 2010;127(12):199-206.
12. Lompara BT, Capuzzi DM, Morgan JM, Brusco OA, Intenzo CM. Indian Onion is the best: Hypercholesterolemia. Curr Atheroscler Rep 2010;2(1):64- mechanisms take place to protect the cell against oxidative damage. 71.
13. JB Kattaria, LK Mokal, SM Fride Henger. Use of Allium cepa for inflammation and atherosclerosis. Journal of atherosclerosis and thrombosis 2010;17(4):332-41.
14. Makrove N, Tappy L., Le K.A., Tran C., Paquot N. Herbs with antioxidant effects. Nutrition 2010;26:1044-49.
15. Plomaya B, Jenner A, Halliwell B, Rafter J. Use of Allium C in dyslipidemia. Am J Clin Nutr 2010;81:268-76.
16. Mutillakave T, Rusle E, Khitan Z., Kim D.H. Fructose: Use of herbs in metabolic syndrome and hypertension. J. Nutr. Metab. 2013;13:1-12.
17. Jaber L, Kolava N, Samwavwe J. onion affects endothelium-dependent relaxation and NADPH oxidase activity. J Phytoch. 2012;17)3):4544-9.
18. Shokave ET, Holayate BV, Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS. Ginger is hypolipidemic agent in herbs. Curr Vasc Pharmacol. 2010;8:612-631.
19. Shan M, Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Zingiber Officinale contains phytochemical which are antixidants. Circulation. 2012;115:450-8.
20. Lovata Y.U, Bjerregaard L.J, Joensen A.M, Dethlefsen C. Various herbs act as antioxidant agents. Eur Heart J. 2010;31:29-34.
21. Sama Y.T, Balk E.M, Tatsioni A, Lichtenstein A.H, Lau J, Pittas A.G. Reactive oxygen species (ROS) and use of medicinal herbs. Diabetes Care. 2010;30:2154-63.
22. Agatave C.N, Bertelli A.A, Das D.K. Gingerol in Zingiber Officinale reduces risk of CAD. J Cardiovasc Pharmacol.2013;54:468–76.
23. S Dakson, Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, Kropp S, Helmbold I, Fournier DV, Haase W. HYPERCHOLESTEROLIMIA: how to deal with? Clin Pharma Res.2016;17:8063-70.
24. Noreara N, Akimoto AK, Miranda-Vilela AL, Alves PCZ, Pereira LCS, Lordelo GS, Hiragi CO, Silva ICR, Grisolia CK. Evaluation of gene polymorphisms in exercise-induced oxidative stress and damage. Free Rad Res. 2010;44:322–331.
25. Boreera C, Akyol O, Yanik M, Elyas H, Namli M, Canatan H, Akin H, Yuce H, Yilmaz HR, Tutkun H, Sogut S. Reactive oxygen species. Biol Psychiatry. 2015;32:1123-31.
26. Gumra TP, Alves-Silva J, Santos MS, Ferreira ACS, Bandelt HJ, Pena SDJ, Prado VF. The Formation of AS Plaques: how to control? Am J Hum Genet. 2016;67:444–461.
27. Sodagarr E, Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 2016;70:1602-26.
28. Makoira IJ, Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Ginger: new concepts to herbs. Nat Phyto. 2016;49:840-45.
29. Vulvaar K, Bastaki M, Huen K, Manzanillo P, Chande N, Chen C, Balmes JR,
36. Mustavye J, Plover, M.; Kaminnaw E.; Fabry, Z.; Qing, Z.; Hart, M. N.; Sandor, M. Fruits/vegetables and their phytochemicals. J Nut Phyto. 2012;78(4):1244-8.
37. Gager T, Connor, W.E., Connor, S.L. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol. 2012;82:82-4.
38. Floreie C, Olszewska M, Glowacki R, Wolbis M, Bald E. ROS and cell damage/protection by nature. Acta Pol Pharm 2011;30(2):199-203.
39. Gume , G.T., Chen, S.J., Rader, D.J., Tazelaar, J., Kawashiri, M., Gao, G., Wilson, J.M. Prolonged correction of hyperlipidemia and process of apoptosis. Mol Ther. 2010;7:1256-9.
40. Fukeera TY, Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2009;122(6):883-92.
41. Yulvisa D, Schectman, G., Hiatt, J. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals. Am J Med. 2013;111:197-9.
42. Gyvesta Y F, Furberg, C.D., Pitt, B. Quercetin in common onion may cause beneficial effects in old age.Curr Control Trials Cardiovasc Med. 2011;9:1205-7.
43. Noor M, Furkan A, Mohammad A, Shah M, Shah N. Miraculos hypolipidemic plants in Pakistan. J Cl Med 2014;12(2):334-9.
44. Jan MM, Fohsin JJ, Lukver TT, Dohmerve VT, Ginsovonenn GF. Onion is best plant to treat hyperlipidemia in albino rats. EJM 2013;2(4):1123-8.
45. Fovuca M, Sulmin S, Kovachi F, Dulhinn D. Hypolipidemic effects of various plants. EJ Cl Cardiol 2013;7(7):435-9.